

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | coenzyme catabolic process (GO:0009109) | 5.70193017 |
| 2 | polyketide metabolic process (GO:0030638) | 4.99314244 |
| 3 | doxorubicin metabolic process (GO:0044598) | 4.99314244 |
| 4 | daunorubicin metabolic process (GO:0044597) | 4.99314244 |
| 5 | response to dietary excess (GO:0002021) | 4.80300637 |
| 6 | cellular modified amino acid catabolic process (GO:0042219) | 4.78004313 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 4.66875513 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.65058134 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.65058134 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.53709820 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.53709820 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.53200158 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.53200158 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48298333 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.48298333 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48298333 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48298333 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48298333 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.48298333 |
| 20 | biotin metabolic process (GO:0006768) | 4.27307698 |
| 21 | proline transport (GO:0015824) | 4.10447470 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.06690736 |
| 23 | maintenance of protein location in nucleus (GO:0051457) | 4.03159874 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 4.01291437 |
| 25 | heme transport (GO:0015886) | 3.97348622 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.92356620 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 3.90323711 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 3.82668466 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.77526368 |
| 30 | hormone catabolic process (GO:0042447) | 3.76933193 |
| 31 | cofactor catabolic process (GO:0051187) | 3.71447394 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.63037403 |
| 33 | cofactor transport (GO:0051181) | 3.56725429 |
| 34 | response to interleukin-15 (GO:0070672) | 3.55689279 |
| 35 | epoxygenase P450 pathway (GO:0019373) | 3.53198330 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.52502870 |
| 37 | cysteine metabolic process (GO:0006534) | 3.50527223 |
| 38 | tryptophan catabolic process (GO:0006569) | 3.43848682 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.43848682 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.43848682 |
| 41 | phenol-containing compound catabolic process (GO:0019336) | 3.41450487 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.41175760 |
| 43 | somite rostral/caudal axis specification (GO:0032525) | 3.40810166 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.33214443 |
| 45 | synaptic vesicle maturation (GO:0016188) | 3.32710076 |
| 46 | bile acid biosynthetic process (GO:0006699) | 3.31325925 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.31062071 |
| 48 | response to peptidoglycan (GO:0032494) | 3.29493501 |
| 49 | alpha-linolenic acid metabolic process (GO:0036109) | 3.28263993 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26153279 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.25550435 |
| 52 | tryptophan metabolic process (GO:0006568) | 3.25453928 |
| 53 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.25400623 |
| 54 | drug metabolic process (GO:0017144) | 3.23261175 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 3.21141236 |
| 56 | neutrophil mediated immunity (GO:0002446) | 3.19785451 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19358044 |
| 58 | response to host immune response (GO:0052572) | 3.19358044 |
| 59 | urea cycle (GO:0000050) | 3.17413532 |
| 60 | urea metabolic process (GO:0019627) | 3.17413532 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.14249498 |
| 62 | cellular extravasation (GO:0045123) | 3.12574227 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.09529577 |
| 64 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.09298120 |
| 65 | iron coordination entity transport (GO:1901678) | 3.07588906 |
| 66 | detection of other organism (GO:0098543) | 3.07505188 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 3.05897054 |
| 68 | germinal center formation (GO:0002467) | 3.05849695 |
| 69 | bile acid metabolic process (GO:0008206) | 3.04512501 |
| 70 | quinone metabolic process (GO:1901661) | 3.02845688 |
| 71 | macrophage activation (GO:0042116) | 3.01688741 |
| 72 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.01157579 |
| 73 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.00723538 |
| 74 | glutamate metabolic process (GO:0006536) | 2.97866520 |
| 75 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97614624 |
| 76 | regulation of cilium movement (GO:0003352) | 2.97529288 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94992418 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.93388283 |
| 79 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91806825 |
| 80 | tyrosine metabolic process (GO:0006570) | 2.91323367 |
| 81 | glyoxylate metabolic process (GO:0046487) | 2.90866452 |
| 82 | response to host defenses (GO:0052200) | 2.89462739 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89462739 |
| 84 | response to host (GO:0075136) | 2.89462739 |
| 85 | glutamate secretion (GO:0014047) | 2.88629540 |
| 86 | triglyceride homeostasis (GO:0070328) | 2.88611240 |
| 87 | acylglycerol homeostasis (GO:0055090) | 2.88611240 |
| 88 | regulation of response to osmotic stress (GO:0047484) | 2.88388767 |
| 89 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87726756 |
| 90 | glycine metabolic process (GO:0006544) | 2.87406826 |
| 91 | negative regulation of fibrinolysis (GO:0051918) | 2.87057765 |
| 92 | neutrophil activation (GO:0042119) | 2.87030988 |
| 93 | detection of external biotic stimulus (GO:0098581) | 2.86072331 |
| 94 | nitrogen cycle metabolic process (GO:0071941) | 2.85131684 |
| 95 | protein carboxylation (GO:0018214) | 2.84263160 |
| 96 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.84263160 |
| 97 | vitamin transmembrane transport (GO:0035461) | 2.82778720 |
| 98 | detection of bacterium (GO:0016045) | 2.82395669 |
| 99 | granulocyte activation (GO:0036230) | 2.81461291 |
| 100 | regulation of gamma-delta T cell activation (GO:0046643) | 2.80994142 |
| 101 | leukocyte aggregation (GO:0070486) | 2.80808697 |
| 102 | regulation of fibrinolysis (GO:0051917) | 2.79945805 |
| 103 | regulation of cellular amide metabolic process (GO:0034248) | 2.78556887 |
| 104 | microglial cell activation (GO:0001774) | 2.77574418 |
| 105 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.77534512 |
| 106 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.77238016 |
| 107 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.77174350 |
| 108 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.76887333 |
| 109 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.76550239 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.76540772 |
| 111 | homocysteine metabolic process (GO:0050667) | 2.76500628 |
| 112 | serine family amino acid metabolic process (GO:0009069) | 2.76479514 |
| 113 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.75046092 |
| 114 | regulation of protein activation cascade (GO:2000257) | 2.74770197 |
| 115 | complement activation, alternative pathway (GO:0006957) | 2.73777248 |
| 116 | respiratory burst (GO:0045730) | 2.71865326 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70847737 |
| 118 | myeloid leukocyte mediated immunity (GO:0002444) | 2.70091179 |
| 119 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.69428427 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.69161853 |
| 121 | regulation of regulated secretory pathway (GO:1903305) | 2.68755680 |
| 122 | amino-acid betaine metabolic process (GO:0006577) | 2.68134099 |
| 123 | response to type I interferon (GO:0034340) | 2.66860674 |
| 124 | regulation of cholesterol esterification (GO:0010872) | 2.66412086 |
| 125 | negative regulation of telomerase activity (GO:0051974) | 2.65986426 |
| 126 | modified amino acid transport (GO:0072337) | 2.64642346 |
| 127 | type I interferon signaling pathway (GO:0060337) | 2.64516363 |
| 128 | cellular response to type I interferon (GO:0071357) | 2.64516363 |
| 129 | NIK/NF-kappaB signaling (GO:0038061) | 2.64350969 |
| 130 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64161100 |
| 131 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63473232 |
| 132 | rRNA transcription (GO:0009303) | 2.63465195 |
| 133 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.63380066 |
| 134 | T-helper cell differentiation (GO:0042093) | 2.63380066 |
| 135 | reverse cholesterol transport (GO:0043691) | 2.63367114 |
| 136 | positive regulation of regulated secretory pathway (GO:1903307) | 2.63231926 |
| 137 | flavonoid metabolic process (GO:0009812) | 2.62891227 |
| 138 | neutrophil activation involved in immune response (GO:0002283) | 2.61455155 |
| 139 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.60906131 |
| 140 | regulation of cholesterol homeostasis (GO:2000188) | 2.60702016 |
| 141 | negative regulation of interleukin-6 production (GO:0032715) | 2.59880813 |
| 142 | fructose metabolic process (GO:0006000) | 2.58789019 |
| 143 | peroxisome fission (GO:0016559) | 2.58080958 |
| 144 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.57363259 |
| 145 | macromolecular complex remodeling (GO:0034367) | 2.56875577 |
| 146 | plasma lipoprotein particle remodeling (GO:0034369) | 2.56875577 |
| 147 | protein-lipid complex remodeling (GO:0034368) | 2.56875577 |
| 148 | organic acid catabolic process (GO:0016054) | 2.56703709 |
| 149 | carboxylic acid catabolic process (GO:0046395) | 2.56703709 |
| 150 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.56306205 |
| 151 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.56306205 |
| 152 | phagosome maturation (GO:0090382) | 2.56100973 |
| 153 | acetyl-CoA metabolic process (GO:0006084) | 2.55000239 |
| 154 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.54774827 |
| 155 | lysine catabolic process (GO:0006554) | 2.54720972 |
| 156 | lysine metabolic process (GO:0006553) | 2.54720972 |
| 157 | gamma-aminobutyric acid transport (GO:0015812) | 2.54516436 |
| 158 | regulation of interferon-alpha production (GO:0032647) | 2.54464461 |
| 159 | interferon-gamma secretion (GO:0072643) | 2.53723485 |
| 160 | myeloid cell activation involved in immune response (GO:0002275) | 2.53654535 |
| 161 | mitochondrion distribution (GO:0048311) | 2.52831952 |
| 162 | L-ascorbic acid metabolic process (GO:0019852) | 2.52669911 |
| 163 | regulation of complement activation (GO:0030449) | 2.52073911 |
| 164 | indolalkylamine metabolic process (GO:0006586) | 2.51790096 |
| 165 | defense response to protozoan (GO:0042832) | 2.51693593 |
| 166 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.51449512 |
| 167 | interferon-gamma production (GO:0032609) | 2.51053558 |
| 168 | bile acid and bile salt transport (GO:0015721) | 2.50595360 |
| 169 | positive regulation of interferon-alpha production (GO:0032727) | 2.50354862 |
| 170 | branched-chain amino acid catabolic process (GO:0009083) | 2.49919330 |
| 171 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.49890560 |
| 172 | regulation of mast cell degranulation (GO:0043304) | 2.49849207 |
| 173 | synaptic vesicle exocytosis (GO:0016079) | 2.48708151 |
| 174 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.48584844 |
| 175 | receptor recycling (GO:0001881) | 2.48536637 |
| 176 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.47277481 |
| 177 | negative regulation of B cell mediated immunity (GO:0002713) | 2.47277481 |
| 178 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.44586824 |
| 179 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44507043 |
| 180 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.44326666 |
| 181 | response to muramyl dipeptide (GO:0032495) | 2.43898163 |
| 182 | positive regulation of granulocyte differentiation (GO:0030854) | 2.41284693 |
| 183 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.38271309 |
| 184 | immunoglobulin mediated immune response (GO:0016064) | 2.38147227 |
| 185 | detection of biotic stimulus (GO:0009595) | 2.37614375 |
| 186 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.35861721 |
| 187 | regulation of leukocyte degranulation (GO:0043300) | 2.35603588 |
| 188 | positive regulation of interferon-beta production (GO:0032728) | 2.35117628 |
| 189 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.34945204 |
| 190 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.34766200 |
| 191 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.34026453 |
| 192 | mitochondrion degradation (GO:0000422) | 2.33899546 |
| 193 | regulation of ARF protein signal transduction (GO:0032012) | 2.33535897 |
| 194 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.33384799 |
| 195 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.32353931 |
| 196 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.32326343 |
| 197 | T cell differentiation involved in immune response (GO:0002292) | 2.32326343 |
| 198 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.32326343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.02183887 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.29351260 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.95020330 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.95020330 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.95020330 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93638465 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.21298114 |
| 8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.20797989 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.13312562 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03197954 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.77228582 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76187727 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.68031068 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.66841797 |
| 15 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.62628607 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.56302184 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40275242 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36166655 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34478425 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.33906914 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.31730154 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.16933281 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15646359 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.11404984 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10718767 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.05192042 |
| 27 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.03450086 |
| 28 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.02467401 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.01478111 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.97249620 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96091066 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94705532 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.87900677 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86083410 |
| 35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.84939821 |
| 36 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.79025849 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77339399 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.75663076 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72736745 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.72605450 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.71763311 |
| 42 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.70681236 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69004143 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67296397 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66288110 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66257946 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62975006 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.61188804 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60575672 |
| 50 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59367619 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59214031 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58396629 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.57256630 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57080626 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56254780 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56225521 |
| 57 | * MAF_26560356_Chip-Seq_TH2_Human | 1.55936100 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55127976 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54432009 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.52367803 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49086203 |
| 62 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.47721880 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46182974 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45722655 |
| 65 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.44312891 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43871214 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41515747 |
| 68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41113595 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40765087 |
| 70 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.40553278 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.39931233 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39690726 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39636572 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37813721 |
| 75 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37213118 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36204038 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36022551 |
| 78 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.35508612 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35411831 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35258713 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33582571 |
| 82 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.33150702 |
| 83 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33082442 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33058482 |
| 85 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.32712256 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32255291 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30726311 |
| 88 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.30681762 |
| 89 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.30658610 |
| 90 | * MYB_26560356_Chip-Seq_TH2_Human | 1.29578605 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27695717 |
| 92 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27432690 |
| 93 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25866177 |
| 94 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.24954046 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24611208 |
| 96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24476633 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23118614 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.22803595 |
| 99 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.22215463 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21921072 |
| 101 | MYB_26560356_Chip-Seq_TH1_Human | 1.21018094 |
| 102 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20385415 |
| 103 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20385415 |
| 104 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19663419 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19441948 |
| 106 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19328328 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19324213 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16929016 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.16604662 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16094923 |
| 111 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.15969587 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14738699 |
| 113 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.14736283 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14681833 |
| 115 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14282710 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14234734 |
| 117 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13765861 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13458319 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 1.13132354 |
| 120 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12838812 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11521601 |
| 122 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11431855 |
| 123 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.11324406 |
| 124 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10734876 |
| 125 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.10044382 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10012005 |
| 127 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09691234 |
| 128 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.08268906 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08255641 |
| 130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08055015 |
| 131 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07865059 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07816569 |
| 133 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07732201 |
| 134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07622702 |
| 135 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06844039 |
| 136 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05692807 |
| 137 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04965969 |
| 138 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.04934733 |
| 139 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03520766 |
| 140 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.02173588 |
| 141 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01842138 |
| 142 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.01359999 |
| 143 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.01141605 |
| 144 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00690237 |
| 145 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.98768366 |
| 146 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.95217427 |
| 147 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94071240 |
| 148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93899112 |
| 149 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93562504 |
| 150 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93271820 |
| 151 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92306384 |
| 152 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.92297776 |
| 153 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91289932 |
| 154 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88350863 |
| 155 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.86640503 |
| 156 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86448460 |
| 157 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.85173460 |
| 158 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84683891 |
| 159 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84419325 |
| 160 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.84392515 |
| 161 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83987831 |
| 162 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.83237120 |
| 163 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83212843 |
| 164 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81598724 |
| 165 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81330612 |
| 166 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81296022 |
| 167 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.79496474 |
| 168 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.77999660 |
| 169 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.77841380 |
| 170 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.77468757 |
| 171 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.77238707 |
| 172 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76521421 |
| 173 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.76025313 |
| 174 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.75544797 |
| 175 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74625353 |
| 176 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.74131026 |
| 177 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.74118287 |
| 178 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72970372 |
| 179 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.72812394 |
| 180 | AR_19668381_ChIP-Seq_PC3_Human | 0.72617829 |
| 181 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.72457371 |
| 182 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.71642712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.88180284 |
| 2 | MP0005360_urolithiasis | 3.98489028 |
| 3 | MP0005365_abnormal_bile_salt | 3.61453891 |
| 4 | MP0003011_delayed_dark_adaptation | 3.53113991 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.49962111 |
| 6 | MP0003436_decreased_susceptibility_to | 3.22143751 |
| 7 | MP0003724_increased_susceptibility_to | 3.19971034 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.17725679 |
| 9 | MP0003303_peritoneal_inflammation | 3.13592810 |
| 10 | MP0002254_reproductive_system_inflammat | 2.74574088 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.62436754 |
| 12 | MP0004858_abnormal_nervous_system | 2.50356282 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.43205386 |
| 14 | MP0008260_abnormal_autophagy | 2.40922575 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.37177556 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.36428760 |
| 17 | MP0004043_abnormal_pH_regulation | 2.32851074 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.27296401 |
| 19 | MP0009840_abnormal_foam_cell | 2.22304928 |
| 20 | MP0006035_abnormal_mitochondrial_morpho | 2.19057076 |
| 21 | MP0002419_abnormal_innate_immunity | 2.15610441 |
| 22 | MP0005499_abnormal_olfactory_system | 2.13366435 |
| 23 | MP0005394_taste/olfaction_phenotype | 2.13366435 |
| 24 | MP0003890_abnormal_embryonic-extraembry | 2.04172604 |
| 25 | MP0002822_catalepsy | 2.03699054 |
| 26 | MP0000685_abnormal_immune_system | 2.03663933 |
| 27 | MP0002332_abnormal_exercise_endurance | 2.00754286 |
| 28 | MP0009785_altered_susceptibility_to | 1.98522724 |
| 29 | MP0005310_abnormal_salivary_gland | 1.96146692 |
| 30 | MP0006082_CNS_inflammation | 1.95171321 |
| 31 | MP0004270_analgesia | 1.94607558 |
| 32 | MP0005025_abnormal_response_to | 1.92913785 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.90542701 |
| 34 | MP0001800_abnormal_humoral_immune | 1.88395876 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.85796850 |
| 36 | MP0005387_immune_system_phenotype | 1.83628654 |
| 37 | MP0001790_abnormal_immune_system | 1.83628654 |
| 38 | MP0009046_muscle_twitch | 1.81003334 |
| 39 | MP0005332_abnormal_amino_acid | 1.80915622 |
| 40 | MP0005671_abnormal_response_to | 1.79926230 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.77833195 |
| 42 | MP0003329_amyloid_beta_deposits | 1.77679650 |
| 43 | MP0002723_abnormal_immune_serum | 1.76509564 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.74079516 |
| 45 | MP0002064_seizures | 1.73864879 |
| 46 | MP0003880_abnormal_central_pattern | 1.72993602 |
| 47 | MP0003252_abnormal_bile_duct | 1.72309907 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.71770250 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.71533318 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.69559184 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.67859685 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.67677135 |
| 53 | MP0004381_abnormal_hair_follicle | 1.65974951 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.64663153 |
| 55 | MP0003122_maternal_imprinting | 1.62655501 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.62505380 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.61379614 |
| 58 | MP0001486_abnormal_startle_reflex | 1.60980752 |
| 59 | MP0004233_abnormal_muscle_weight | 1.60689942 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.59860063 |
| 61 | MP0001819_abnormal_immune_cell | 1.58661940 |
| 62 | MP0003195_calcinosis | 1.55889181 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.53577881 |
| 64 | MP0004510_myositis | 1.52060611 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.46918137 |
| 66 | MP0000609_abnormal_liver_physiology | 1.46635364 |
| 67 | MP0008961_abnormal_basal_metabolism | 1.46465891 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.46450730 |
| 69 | MP0009745_abnormal_behavioral_response | 1.43625353 |
| 70 | MP0004947_skin_inflammation | 1.41221464 |
| 71 | MP0003075_altered_response_to | 1.39071966 |
| 72 | MP0009764_decreased_sensitivity_to | 1.36504782 |
| 73 | MP0001501_abnormal_sleep_pattern | 1.36380255 |
| 74 | MP0002405_respiratory_system_inflammati | 1.29961887 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.29438289 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.28242702 |
| 77 | MP0001440_abnormal_grooming_behavior | 1.24545332 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 1.24249162 |
| 79 | MP0003879_abnormal_hair_cell | 1.23599863 |
| 80 | MP0002272_abnormal_nervous_system | 1.22845556 |
| 81 | MP0000716_abnormal_immune_system | 1.22594881 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.18807108 |
| 83 | MP0008469_abnormal_protein_level | 1.18764135 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.18750453 |
| 85 | MP0005423_abnormal_somatic_nervous | 1.16461084 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.16289631 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 1.16076316 |
| 88 | MP0000604_amyloidosis | 1.15683919 |
| 89 | MP0002398_abnormal_bone_marrow | 1.15419964 |
| 90 | MP0005266_abnormal_metabolism | 1.15340587 |
| 91 | MP0005535_abnormal_body_temperature | 1.14607474 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 1.13606504 |
| 93 | MP0003763_abnormal_thymus_physiology | 1.13167453 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 1.10369393 |
| 95 | MP0003938_abnormal_ear_development | 1.09940014 |
| 96 | MP0005257_abnormal_intraocular_pressure | 1.09841107 |
| 97 | MP0002733_abnormal_thermal_nociception | 1.09648527 |
| 98 | MP0002653_abnormal_ependyma_morphology | 1.09313556 |
| 99 | MP0008872_abnormal_physiological_respon | 1.09120855 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04773541 |
| 101 | MP0002132_abnormal_respiratory_system | 1.04705242 |
| 102 | MP0001968_abnormal_touch/_nociception | 1.04443106 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 1.04426376 |
| 104 | MP0004142_abnormal_muscle_tone | 1.03682429 |
| 105 | MP0000689_abnormal_spleen_morphology | 1.03472332 |
| 106 | MP0003787_abnormal_imprinting | 1.03154135 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 1.01835360 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 1.01350331 |
| 109 | MP0003690_abnormal_glial_cell | 1.01222617 |
| 110 | MP0003868_abnormal_feces_composition | 1.00279220 |
| 111 | MP0001666_abnormal_nutrient_absorption | 1.00003949 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.99641412 |
| 113 | MP0002722_abnormal_immune_system | 0.98437805 |
| 114 | MP0000678_abnormal_parathyroid_gland | 0.97933924 |
| 115 | MP0005083_abnormal_biliary_tract | 0.97641547 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96577957 |
| 117 | MP0005551_abnormal_eye_electrophysiolog | 0.96221313 |
| 118 | MP0000920_abnormal_myelination | 0.94470783 |
| 119 | MP0002970_abnormal_white_adipose | 0.92947172 |
| 120 | MP0002429_abnormal_blood_cell | 0.92334552 |
| 121 | MP0004885_abnormal_endolymph | 0.91487654 |
| 122 | MP0003866_abnormal_defecation | 0.91055683 |
| 123 | MP0000955_abnormal_spinal_cord | 0.89975742 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.89785275 |
| 125 | MP0005670_abnormal_white_adipose | 0.89233423 |
| 126 | MP0002229_neurodegeneration | 0.88997796 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.88312823 |
| 128 | MP0002837_dystrophic_cardiac_calcinosis | 0.86925048 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.86844030 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.86312457 |
| 131 | MP0001970_abnormal_pain_threshold | 0.86217920 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.85441251 |
| 133 | MP0005448_abnormal_energy_balance | 0.84552493 |
| 134 | MP0002090_abnormal_vision | 0.82024839 |
| 135 | MP0009780_abnormal_chondrocyte_physiolo | 0.80104123 |
| 136 | MP0003828_pulmonary_edema | 0.79775431 |
| 137 | MP0010155_abnormal_intestine_physiology | 0.77783234 |
| 138 | MP0001873_stomach_inflammation | 0.77310623 |
| 139 | MP0001851_eye_inflammation | 0.76499550 |
| 140 | MP0002693_abnormal_pancreas_physiology | 0.76004851 |
| 141 | MP0006276_abnormal_autonomic_nervous | 0.74506110 |
| 142 | MP0005452_abnormal_adipose_tissue | 0.74088258 |
| 143 | MP0005376_homeostasis/metabolism_phenot | 0.73532909 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.73102383 |
| 145 | MP0002069_abnormal_eating/drinking_beha | 0.72673226 |
| 146 | MP0002066_abnormal_motor_capabilities/c | 0.72253241 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.72096950 |
| 148 | MP0002067_abnormal_sensory_capabilities | 0.71217656 |
| 149 | MP0002269_muscular_atrophy | 0.70864268 |
| 150 | MP0002184_abnormal_innervation | 0.68468259 |
| 151 | MP0001905_abnormal_dopamine_level | 0.68392990 |
| 152 | MP0001661_extended_life_span | 0.68296510 |
| 153 | MP0005248_abnormal_Harderian_gland | 0.67381492 |
| 154 | MP0005451_abnormal_body_composition | 0.66354392 |
| 155 | MP0008874_decreased_physiological_sensi | 0.66093458 |
| 156 | MP0005386_behavior/neurological_phenoty | 0.65872634 |
| 157 | MP0004924_abnormal_behavior | 0.65872634 |
| 158 | MP0005379_endocrine/exocrine_gland_phen | 0.65041468 |
| 159 | MP0002971_abnormal_brown_adipose | 0.64350962 |
| 160 | MP0001529_abnormal_vocalization | 0.64128232 |
| 161 | MP0001984_abnormal_olfaction | 0.63436936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 5.43561859 |
| 2 | Orchitis (HP:0100796) | 5.30775956 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.05555828 |
| 4 | Optic neuritis (HP:0100653) | 5.05555828 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 5.01530700 |
| 6 | Myositis (HP:0100614) | 4.81713955 |
| 7 | Bilateral microphthalmos (HP:0007633) | 4.51508587 |
| 8 | Stomatitis (HP:0010280) | 4.31387608 |
| 9 | Hyperventilation (HP:0002883) | 4.27614611 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.15641285 |
| 11 | Hyperglycinuria (HP:0003108) | 4.10171317 |
| 12 | Hepatoblastoma (HP:0002884) | 3.95324842 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.95172003 |
| 14 | Gout (HP:0001997) | 3.88927989 |
| 15 | Hyperglycinemia (HP:0002154) | 3.84058375 |
| 16 | Tetraplegia (HP:0002445) | 3.74036152 |
| 17 | Multiple enchondromatosis (HP:0005701) | 3.69953026 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64758333 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.64758333 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.62782335 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.52495511 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.50827997 |
| 23 | Xanthomatosis (HP:0000991) | 3.50672339 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.50115995 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46525874 |
| 26 | Deep venous thrombosis (HP:0002625) | 3.32368934 |
| 27 | Episodic fever (HP:0001954) | 3.24225849 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.20149902 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.17392746 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.14868614 |
| 31 | Skin nodule (HP:0200036) | 3.11438655 |
| 32 | Testicular atrophy (HP:0000029) | 3.07615895 |
| 33 | Keratoconjunctivitis (HP:0001096) | 3.02081609 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.01699172 |
| 35 | Status epilepticus (HP:0002133) | 2.99487429 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.98987210 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 2.97903067 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 2.96421453 |
| 39 | Focal motor seizures (HP:0011153) | 2.94890443 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.86851832 |
| 41 | Ketosis (HP:0001946) | 2.85375797 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.77132610 |
| 43 | Abnormal cartilage morphology (HP:0002763) | 2.76672994 |
| 44 | Hyperammonemia (HP:0001987) | 2.75895635 |
| 45 | Dialeptic seizures (HP:0011146) | 2.75737195 |
| 46 | Epileptic encephalopathy (HP:0200134) | 2.75543000 |
| 47 | Anorexia (HP:0002039) | 2.75248871 |
| 48 | Spastic tetraparesis (HP:0001285) | 2.74641021 |
| 49 | Focal seizures (HP:0007359) | 2.73292843 |
| 50 | Ketoacidosis (HP:0001993) | 2.69857293 |
| 51 | Hypobetalipoproteinemia (HP:0003563) | 2.68884283 |
| 52 | Amyotrophic lateral sclerosis (HP:0007354) | 2.67032740 |
| 53 | Ragged-red muscle fibers (HP:0003200) | 2.64342178 |
| 54 | Ankle clonus (HP:0011448) | 2.61605312 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58441575 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58441575 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58441575 |
| 58 | Peripheral hypomyelination (HP:0007182) | 2.58207595 |
| 59 | Hypoplasia of the fovea (HP:0007750) | 2.53696027 |
| 60 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.53696027 |
| 61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52859503 |
| 62 | Malnutrition (HP:0004395) | 2.51802911 |
| 63 | Recurrent fungal infections (HP:0002841) | 2.51606829 |
| 64 | Generalized myoclonic seizures (HP:0002123) | 2.51103559 |
| 65 | Encephalitis (HP:0002383) | 2.50884386 |
| 66 | Irritability (HP:0000737) | 2.49972264 |
| 67 | Loss of speech (HP:0002371) | 2.49617109 |
| 68 | Generalized tonic-clonic seizures (HP:0002069) | 2.48832002 |
| 69 | Atonic seizures (HP:0010819) | 2.48224556 |
| 70 | Progressive inability to walk (HP:0002505) | 2.48036018 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.46271411 |
| 72 | Febrile seizures (HP:0002373) | 2.45791457 |
| 73 | Hemiparesis (HP:0001269) | 2.45627287 |
| 74 | Slow saccadic eye movements (HP:0000514) | 2.45042718 |
| 75 | Upper motor neuron abnormality (HP:0002127) | 2.44790366 |
| 76 | Postural instability (HP:0002172) | 2.42525438 |
| 77 | Hypokinesia (HP:0002375) | 2.39812346 |
| 78 | Mutism (HP:0002300) | 2.39685269 |
| 79 | Albinism (HP:0001022) | 2.39362767 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 2.37250782 |
| 81 | Visual hallucinations (HP:0002367) | 2.36401474 |
| 82 | Amblyopia (HP:0000646) | 2.36392729 |
| 83 | Hypochromic anemia (HP:0001931) | 2.34038516 |
| 84 | Supranuclear gaze palsy (HP:0000605) | 2.31527102 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29754038 |
| 86 | Hemoptysis (HP:0002105) | 2.29247886 |
| 87 | Absence seizures (HP:0002121) | 2.29227532 |
| 88 | Gingivitis (HP:0000230) | 2.28165369 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.27381479 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 2.26584899 |
| 91 | Cheilitis (HP:0100825) | 2.25766148 |
| 92 | Hypolipoproteinemia (HP:0010981) | 2.25490691 |
| 93 | Vasculitis (HP:0002633) | 2.25089143 |
| 94 | Complement deficiency (HP:0004431) | 2.24360750 |
| 95 | Recurrent skin infections (HP:0001581) | 2.23825672 |
| 96 | Abnormality of glycolysis (HP:0004366) | 2.23740235 |
| 97 | Increased serum pyruvate (HP:0003542) | 2.23740235 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.22974645 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22974645 |
| 100 | Urticaria (HP:0001025) | 2.21812302 |
| 101 | Resting tremor (HP:0002322) | 2.18535415 |
| 102 | Neurofibrillary tangles (HP:0002185) | 2.18091365 |
| 103 | Sensory axonal neuropathy (HP:0003390) | 2.17797165 |
| 104 | Global brain atrophy (HP:0002283) | 2.17670503 |
| 105 | Cerebral inclusion bodies (HP:0100314) | 2.16478327 |
| 106 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15796133 |
| 107 | Amyloidosis (HP:0011034) | 2.15701333 |
| 108 | Horizontal nystagmus (HP:0000666) | 2.15564603 |
| 109 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11601837 |
| 110 | Meningitis (HP:0001287) | 2.10371139 |
| 111 | Gingival bleeding (HP:0000225) | 2.09966940 |
| 112 | Anomalous pulmonary venous return (HP:0010772) | 2.09766800 |
| 113 | Progressive cerebellar ataxia (HP:0002073) | 2.09672052 |
| 114 | Achilles tendon contracture (HP:0001771) | 2.08749585 |
| 115 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06795025 |
| 116 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06795025 |
| 117 | Abnormality of the endocardium (HP:0004306) | 2.06214216 |
| 118 | Dysostosis multiplex (HP:0000943) | 2.06006928 |
| 119 | Arterial thrombosis (HP:0004420) | 2.05189682 |
| 120 | Pulmonary infiltrates (HP:0002113) | 2.04802352 |
| 121 | Generalized hypotonia (HP:0001290) | 2.03496799 |
| 122 | Clumsiness (HP:0002312) | 2.03120859 |
| 123 | Progressive muscle weakness (HP:0003323) | 2.03119884 |
| 124 | Abnormal gallbladder physiology (HP:0012438) | 2.02962391 |
| 125 | Cholecystitis (HP:0001082) | 2.02962391 |
| 126 | Hypoglycemic coma (HP:0001325) | 2.01862890 |
| 127 | Abnormality of the fovea (HP:0000493) | 2.01589444 |
| 128 | Epidermoid cyst (HP:0200040) | 2.01571262 |
| 129 | Drooling (HP:0002307) | 1.99649920 |
| 130 | Excessive salivation (HP:0003781) | 1.99649920 |
| 131 | Keratitis (HP:0000491) | 1.98870694 |
| 132 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.98696198 |
| 133 | Inability to walk (HP:0002540) | 1.98280151 |
| 134 | Pulmonary embolism (HP:0002204) | 1.97418675 |
| 135 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96939830 |
| 136 | Progressive neurologic deterioration (HP:0002344) | 1.96648249 |
| 137 | Rib fusion (HP:0000902) | 1.96602354 |
| 138 | Spastic gait (HP:0002064) | 1.95828914 |
| 139 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.95472042 |
| 140 | Severe global developmental delay (HP:0011344) | 1.95323791 |
| 141 | Metabolic acidosis (HP:0001942) | 1.94911112 |
| 142 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.94256220 |
| 143 | Absent speech (HP:0001344) | 1.93989153 |
| 144 | Agitation (HP:0000713) | 1.93370563 |
| 145 | Neuronal loss in central nervous system (HP:0002529) | 1.92744197 |
| 146 | Progressive external ophthalmoplegia (HP:0000590) | 1.92541074 |
| 147 | Joint hemorrhage (HP:0005261) | 1.91140176 |
| 148 | Gangrene (HP:0100758) | 1.90878324 |
| 149 | Abnormal gallbladder morphology (HP:0012437) | 1.90397130 |
| 150 | Decreased motor nerve conduction velocity (HP:0003431) | 1.90352785 |
| 151 | Ependymoma (HP:0002888) | 1.89630725 |
| 152 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.88920506 |
| 153 | Abnormality of serum amino acid levels (HP:0003112) | 1.88504350 |
| 154 | Cholelithiasis (HP:0001081) | 1.88134999 |
| 155 | Chest pain (HP:0100749) | 1.87149451 |
| 156 | Abnormality of the pericardium (HP:0001697) | 1.87111026 |
| 157 | Hypercholesterolemia (HP:0003124) | 1.86954837 |
| 158 | Mitral stenosis (HP:0001718) | 1.86630960 |
| 159 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.86146566 |
| 160 | Ocular albinism (HP:0001107) | 1.85374743 |
| 161 | Bifid tongue (HP:0010297) | 1.85178483 |
| 162 | Lethargy (HP:0001254) | 1.84737789 |
| 163 | Delayed CNS myelination (HP:0002188) | 1.84200401 |
| 164 | Delusions (HP:0000746) | 1.83606501 |
| 165 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82308548 |
| 166 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82308548 |
| 167 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82308548 |
| 168 | Neoplasm of striated muscle (HP:0009728) | 1.81923392 |
| 169 | Abnormality of purine metabolism (HP:0004352) | 1.81911591 |
| 170 | Myokymia (HP:0002411) | 1.80475559 |
| 171 | Limb hypertonia (HP:0002509) | 1.80453207 |
| 172 | Increased purine levels (HP:0004368) | 1.80380426 |
| 173 | Diplopia (HP:0000651) | 1.79274852 |
| 174 | Abnormality of binocular vision (HP:0011514) | 1.79274852 |
| 175 | Diminished motivation (HP:0000745) | 1.78211484 |
| 176 | Rigidity (HP:0002063) | 1.78190899 |
| 177 | Intellectual disability, progressive (HP:0006887) | 1.77820429 |
| 178 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73783726 |
| 179 | Bradykinesia (HP:0002067) | 1.73678794 |
| 180 | Obstructive lung disease (HP:0006536) | 1.73538974 |
| 181 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73538974 |
| 182 | Acne (HP:0001061) | 1.73258007 |
| 183 | Increased serum ferritin (HP:0003281) | 1.72799900 |
| 184 | Onion bulb formation (HP:0003383) | 1.72679691 |
| 185 | Muscle fibrillation (HP:0010546) | 1.69248789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK5 | 5.24993278 |
| 2 | CDK12 | 4.85552706 |
| 3 | GRK6 | 3.66456333 |
| 4 | ERN1 | 3.51190137 |
| 5 | EPHA4 | 3.05026085 |
| 6 | MAP2K3 | 2.80377729 |
| 7 | SIK2 | 2.77517367 |
| 8 | SIK3 | 2.68449243 |
| 9 | MAP2K4 | 2.64681090 |
| 10 | ADRBK2 | 2.62551034 |
| 11 | EPHB1 | 2.51730346 |
| 12 | TYRO3 | 2.51278233 |
| 13 | NTRK1 | 2.48780539 |
| 14 | GRK1 | 2.48513146 |
| 15 | NTRK3 | 2.47352522 |
| 16 | AKT3 | 2.33788571 |
| 17 | MAP3K9 | 2.32908771 |
| 18 | IRAK4 | 1.98517283 |
| 19 | MAP3K3 | 1.96502473 |
| 20 | TAOK2 | 1.95872532 |
| 21 | MAP2K6 | 1.88088809 |
| 22 | MAP4K1 | 1.83473010 |
| 23 | GRK7 | 1.78704624 |
| 24 | MAPK7 | 1.76084049 |
| 25 | TNK2 | 1.73343284 |
| 26 | MAP3K14 | 1.71129289 |
| 27 | MAP3K4 | 1.58797355 |
| 28 | LATS2 | 1.55449084 |
| 29 | BLK | 1.54474484 |
| 30 | WNK1 | 1.53707603 |
| 31 | PAK6 | 1.53364937 |
| 32 | TTK | 1.52487239 |
| 33 | CSF1R | 1.51314977 |
| 34 | BCKDK | 1.49665233 |
| 35 | FES | 1.46978445 |
| 36 | ZAP70 | 1.46244339 |
| 37 | MOS | 1.38498759 |
| 38 | TESK2 | 1.35398143 |
| 39 | CSK | 1.35326369 |
| 40 | INSRR | 1.35097491 |
| 41 | MARK2 | 1.34059415 |
| 42 | MAP3K11 | 1.30334166 |
| 43 | IKBKE | 1.29943426 |
| 44 | DAPK2 | 1.29657897 |
| 45 | TYK2 | 1.28807696 |
| 46 | MARK3 | 1.22712187 |
| 47 | TXK | 1.21406823 |
| 48 | MAP3K1 | 1.21269503 |
| 49 | NTRK2 | 1.20570784 |
| 50 | MAP3K6 | 1.17840230 |
| 51 | JAK2 | 1.17149564 |
| 52 | IRAK1 | 1.16930019 |
| 53 | PRKCG | 1.15797700 |
| 54 | CAMK4 | 1.15279525 |
| 55 | KSR2 | 1.14788279 |
| 56 | MAP3K5 | 1.14705732 |
| 57 | STK38 | 1.13709347 |
| 58 | TBK1 | 1.12539358 |
| 59 | CAMK1D | 1.11918419 |
| 60 | PRKD2 | 1.10007416 |
| 61 | SRPK1 | 1.09371013 |
| 62 | CHUK | 1.06773222 |
| 63 | MARK1 | 1.04476108 |
| 64 | FRK | 1.03094912 |
| 65 | HCK | 1.02501285 |
| 66 | ARAF | 0.97878154 |
| 67 | PRPF4B | 0.93750418 |
| 68 | CAMKK2 | 0.93102567 |
| 69 | BRD4 | 0.92830005 |
| 70 | MAP3K13 | 0.92360895 |
| 71 | ADRBK1 | 0.91450450 |
| 72 | MAP2K7 | 0.90830533 |
| 73 | ERBB4 | 0.89309309 |
| 74 | FGR | 0.89302167 |
| 75 | IKBKB | 0.88957890 |
| 76 | PAK3 | 0.87261145 |
| 77 | PRKD3 | 0.87072007 |
| 78 | SMG1 | 0.84568022 |
| 79 | SIK1 | 0.83381338 |
| 80 | IRAK3 | 0.83333594 |
| 81 | JAK3 | 0.83318841 |
| 82 | JAK1 | 0.82439083 |
| 83 | RIPK4 | 0.82274626 |
| 84 | MINK1 | 0.80921582 |
| 85 | MAPK12 | 0.80813270 |
| 86 | MATK | 0.80630058 |
| 87 | PINK1 | 0.80368029 |
| 88 | HIPK2 | 0.78238353 |
| 89 | CDK5 | 0.77176548 |
| 90 | PRKAA1 | 0.76797383 |
| 91 | SYK | 0.75485610 |
| 92 | YES1 | 0.72777584 |
| 93 | ALK | 0.71152893 |
| 94 | DYRK1A | 0.68821156 |
| 95 | EPHA3 | 0.67816178 |
| 96 | LMTK2 | 0.67083268 |
| 97 | IRAK2 | 0.64819721 |
| 98 | MAP3K7 | 0.64006360 |
| 99 | MAPK11 | 0.63253997 |
| 100 | SGK3 | 0.61627525 |
| 101 | ABL2 | 0.58874235 |
| 102 | PRKACG | 0.58763128 |
| 103 | PDK2 | 0.57601276 |
| 104 | TGFBR2 | 0.57030878 |
| 105 | TAOK3 | 0.56280091 |
| 106 | LCK | 0.56267678 |
| 107 | TAOK1 | 0.54510246 |
| 108 | ICK | 0.54165084 |
| 109 | PDK4 | 0.53727349 |
| 110 | PDK3 | 0.53727349 |
| 111 | MAPK10 | 0.53618624 |
| 112 | CASK | 0.52888947 |
| 113 | KSR1 | 0.51832981 |
| 114 | PRKG2 | 0.51279174 |
| 115 | CSNK1E | 0.51151683 |
| 116 | CDK15 | 0.51013726 |
| 117 | LYN | 0.50964362 |
| 118 | NEK6 | 0.50783397 |
| 119 | PTK2 | 0.50744125 |
| 120 | SGK494 | 0.50396885 |
| 121 | SGK223 | 0.50396885 |
| 122 | RPS6KA3 | 0.49759163 |
| 123 | CDC42BPA | 0.49260127 |
| 124 | OXSR1 | 0.48303422 |
| 125 | CHEK2 | 0.46543718 |
| 126 | CDK18 | 0.45731242 |
| 127 | SGK2 | 0.45522934 |
| 128 | CSNK1G2 | 0.45494778 |
| 129 | CAMKK1 | 0.45101992 |
| 130 | CAMK1G | 0.44746897 |
| 131 | STK10 | 0.44448589 |
| 132 | CAMK2A | 0.43749339 |
| 133 | DAPK1 | 0.43441326 |
| 134 | MAP3K2 | 0.43244628 |
| 135 | PRKACA | 0.43198925 |
| 136 | LRRK2 | 0.43028662 |
| 137 | CDK14 | 0.42841620 |
| 138 | PDK1 | 0.42825790 |
| 139 | RAF1 | 0.42697835 |
| 140 | BRAF | 0.40332581 |
| 141 | CAMK1 | 0.40232653 |
| 142 | AKT2 | 0.40173137 |
| 143 | CDK11A | 0.39715411 |
| 144 | PRKCZ | 0.39566078 |
| 145 | PRKCH | 0.39406214 |
| 146 | BTK | 0.38983424 |
| 147 | PRKCI | 0.38837995 |
| 148 | PLK2 | 0.38333213 |
| 149 | TRIB3 | 0.38180089 |
| 150 | PDPK1 | 0.37908649 |
| 151 | STK11 | 0.35299215 |
| 152 | FGFR3 | 0.35194643 |
| 153 | PRKAA2 | 0.33684627 |
| 154 | PLK1 | 0.33667402 |
| 155 | WNK3 | 0.33072517 |
| 156 | PRKACB | 0.32411616 |
| 157 | NME1 | 0.32046877 |
| 158 | PNCK | 0.30250484 |
| 159 | BRSK1 | 0.30221223 |
| 160 | IGF1R | 0.30202387 |
| 161 | DYRK2 | 0.28458980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.27576692 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.97613520 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.89543540 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49863617 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.43168383 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24971720 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22582637 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.19774231 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15655607 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09261255 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05527851 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02760450 |
| 13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.88789928 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85901331 |
| 15 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.85082101 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79760474 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79271213 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77124826 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.76837466 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.75699569 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.72015914 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70151996 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68512206 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62805845 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60025742 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57865342 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.51908896 |
| 28 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.49314703 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49231856 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45868780 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45509643 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43250250 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.43000559 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.40758620 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.40601632 |
| 36 | Nicotine addiction_Homo sapiens_hsa05033 | 1.38953998 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38176683 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38036511 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.34449826 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34087856 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.33987216 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.32614101 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28915682 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.28632769 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27820892 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26738253 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26158686 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25366714 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23714783 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22800321 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22237707 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.20715303 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 1.20001699 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.18848713 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17379676 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14267548 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 1.12133860 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.11443435 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.10196023 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08712834 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08677611 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.07545684 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07342110 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06925515 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06901624 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 1.06268288 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05653432 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04575675 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03736123 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03300142 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03241874 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02507068 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01144047 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 1.00282358 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.99348321 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99206189 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.99023901 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97812429 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97772827 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97618015 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97127273 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95659946 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95557072 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95551535 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95383336 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94591327 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94009476 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93947077 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93486763 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93423588 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93161414 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.92687248 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91486358 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88198610 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87653618 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86827392 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86234169 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85027733 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84765337 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84310982 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83817661 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83756373 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83029663 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82008647 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81188473 |
| 106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81121283 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80851309 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.80151516 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.79032096 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77928729 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77793459 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77140739 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76820079 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76175075 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75983280 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75059082 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74888673 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74143222 |
| 119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73113385 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72887285 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.70452352 |
| 122 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67648933 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67309004 |
| 124 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67063515 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66993521 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.66068192 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.64942415 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.64401416 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63545548 |
| 130 | Allograft rejection_Homo sapiens_hsa05330 | 0.63310214 |
| 131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61245169 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61206837 |
| 133 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60939657 |
| 134 | Morphine addiction_Homo sapiens_hsa05032 | 0.59431336 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58472706 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57400556 |
| 137 | Malaria_Homo sapiens_hsa05144 | 0.57334485 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.57316933 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57294756 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55959282 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55409962 |
| 142 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54687579 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54554374 |
| 144 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53546638 |
| 145 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53389938 |
| 146 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52459929 |
| 147 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50070832 |
| 148 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49614740 |
| 149 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49463449 |
| 150 | Long-term depression_Homo sapiens_hsa04730 | 0.48538356 |
| 151 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47509407 |
| 152 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46269636 |
| 153 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45936265 |
| 154 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45276318 |
| 155 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45009780 |
| 156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44716968 |
| 157 | Prion diseases_Homo sapiens_hsa05020 | 0.44584890 |
| 158 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44131942 |
| 159 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44001281 |
| 160 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43385356 |
| 161 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42572230 |
| 162 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42043382 |
| 163 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41765600 |
| 164 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41089433 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40997553 |
| 166 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38698681 |
| 167 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36535113 |
| 168 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36216525 |
| 169 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.35149973 |
| 170 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34797024 |

